Security Snapshot

ICU MEDICAL INC/DE - Common Stock (ICUI) Institutional Ownership

CUSIP: 44930G107

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

286

Shares (Excl. Options)

26.05MFull value: 26,049,203 · shares · 30 Jun 2026

Price

$146.60

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock
Symbol
ICUI on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
26,049,203
Latest holder snapshot 5 signals
Total 13F value
$3,820,042,951
Portfolio coverage rank
0%
Share change
+936,619
Value change
+$140,451,077
Number of holders
286
Security identity Names, identifiers, and filing context for this profile. 1 source field
Underlying class
Common Stock
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
25,012,080
SEC-reported price per share
$160.51
Insider filing price
$160.51
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • ICUI - ICU MEDICAL INC/DE - Common Stock is tracked under CUSIP 44930G107.
  • 286 institutions reported positions in Q2 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 276 to 286 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $3.23BFull value: $3,225,340,011 · USD · 31 Mar 2026
    to
    $3.82BFull value: $3,820,042,951 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 286 institutions filings for Q2 2026.

Open SEC evidence

Security key

44930G107

13F reference period

Q2 2026

13F holders

286

13D/G owners

4

CIK / CUSIP context first

Open Q2 2026 holders ICUI full holder history ICU MEDICAL INC/DE SEC filings ICU MEDICAL INC/DE company facts ICU MEDICAL INC/DE insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
ICUI
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Janus Henderson Group Ltd. 11% +11% $422,500,414 +$47,309,938 2,781,621 +13% JANUS HENDERSON GROUP Ltd. 30 Jun 2026
VANGUARD PORTFOLIO MANAGEMENT LLC 5.8% $188,012,050 1,455,765 Vanguard Portfolio Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.2% $167,695,980 1,298,459 Vanguard Capital Management 31 Mar 2026
FULLER & THALER ASSET MANAGEMENT, INC. 5.2% +5% $197,172,504 +$11,784,841 1,298,127 +6.4% Fuller & Thaler Asset Management, Inc. 30 Jun 2026
As of 30 Jun 2026, 286 institutional investors reported holding
26.05MFull value: 26,049,203 · shares · 30 Jun 2026
shares of ICU MEDICAL INC/DE - Common Stock (ICUI). This represents 104% of the company’s total
25.01MFull value: 25,012,080 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
82%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 3,753,409 +4% 0.01% $550,249,759
Jupiter Topco LLC 11% 2,781,620 0% 0.17% $407,785,874
VANGUARD PORTFOLIO MANAGEMENT LLC 5.9% 1,470,583 +2.3% 0.01% $215,587,468
FULLER & THALER ASSET MANAGEMENT, INC. 5.2% 1,298,127 +6.4% 0.52% $190,305,412
VANGUARD CAPITAL MANAGEMENT LLC 4.5% 1,123,237 +1% 0% $164,666,544
DIMENSIONAL FUND ADVISORS LP 4.2% 1,053,476 +7.1% 0.03% $154,443,449
STATE STREET CORP 4.1% 1,024,369 +5.8% 0% $150,177,172
SCHRODER INVESTMENT MANAGEMENT GROUP 3% 739,138 +5.4% 0.08% $109,340,684
AMERIPRISE FINANCIAL INC 2.8% 689,573 +14% 0.02% $101,091,847
GEODE CAPITAL MANAGEMENT, LLC 2.6% 660,423 +8.1% 0.01% $96,836,293
River Road Asset Management, LLC 2.5% 626,290 -3.1% 1% $91,814,114
CITADEL ADVISORS LLC 2.1% 536,225 +61% 0.05% $78,610,585
NEUBERGER BERMAN GROUP LLC 1.8% 451,279 +1.1% 0.04% $66,157,502
JPMORGAN CHASE & CO 1.8% 440,468 -5.8% 0% $65,312,452
GOLDMAN SACHS GROUP INC 1.7% 417,342 +29% 0.01% $61,182,264
Thrivent Financial for Lutherans 1.5% 381,139 -12% 0.09% $55,875,000
MORGAN STANLEY 1.5% 372,583 -29% 0% $54,620,878
BANK OF AMERICA CORP /DE/ 1.5% 368,754 +11% 0% $54,059,336
TORONTO DOMINION BANK 1.4% 358,023 +71% 0.09% $52,486,172
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.3% 331,052 +2.7% 0.01% $48,532,223
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 1.3% 328,969 +12% 0.07% $48,227,000
REINHART PARTNERS, LLC. 1.3% 314,768 1.1% $46,147,615
SILVERCREST ASSET MANAGEMENT GROUP LLC 1.2% 297,505 -8.1% 0.29% $43,614,563
NORTHERN TRUST CORP 1.2% 295,779 +0.71% 0.01% $43,361,202
FMR LLC 1.1% 283,195 -9.5% 0% $41,516,428

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q2 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 538,478 $86,436,832 +$5,077,891 $160.51 63
2026 Q2 26,049,203 $3,820,042,951 +$140,451,077 $146.60 286
2026 Q1 25,008,537 $3,225,340,011 -$93,215,190 $129.15 276
2025 Q4 25,641,980 $3,660,360,413 -$111,554,319 $142.67 292
2025 Q3 25,796,286 $3,091,441,219 +$77,553,211 $119.96 268
2025 Q2 25,082,538 $3,314,262,195 +$97,749,003 $132.15 273
2025 Q1 24,312,384 $3,381,985,980 +$22,039,356 $138.86 281
2024 Q4 24,213,401 $3,756,909,626 -$58,516,049 $155.17 285
2024 Q3 24,553,720 $4,467,331,041 +$76,905,236 $182.22 287
2024 Q2 23,790,393 $2,825,088,620 +$149,203,804 $118.75 256
2024 Q1 22,617,632 $2,427,031,471 +$116,351,455 $107.32 251
2023 Q4 21,600,686 $2,154,454,730 -$89,807,764 $99.74 241
2023 Q3 22,298,221 $2,653,725,397 -$35,106,953 $119.01 215
2023 Q2 22,249,048 $3,964,270,637 -$74,461,498 $178.19 227
2023 Q1 22,697,462 $3,743,979,121 +$70,541,615 $164.96 231
2022 Q4 22,295,759 $3,511,926,675 +$39,756,872 $157.48 241
2022 Q3 22,630,155 $3,408,280,475 -$240,293,324 $150.60 231
2022 Q2 21,624,606 $3,556,543,462 +$100,918,106 $164.39 246
2022 Q1 20,908,251 $4,657,377,472 +$150,898,618 $222.64 282
2021 Q4 20,185,157 $4,789,939,188 +$34,827,837 $237.34 288
2021 Q3 19,964,154 $4,660,018,823 -$53,955,352 $233.38 272
2021 Q2 20,303,486 $4,177,920,660 +$50,461,509 $205.80 266
2021 Q1 20,080,347 $4,125,473,068 +$114,043,017 $205.44 277
2020 Q4 19,530,259 $4,188,765,735 +$40,730,429 $214.49 273
2020 Q3 19,335,530 $3,533,762,551 -$33,121,822 $182.76 273
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .